On the recordSeptember 29, 2020
Your company has made more than $34 billion--$34 billion--from Copaxone but it reported to the committee that it has spent two percent of that on R&D expenditures for Copaxone patients.
Source
congress.govJamie Raskin: “Your company has made more than $34 billion--$34 billion--from Copaxone but it reported to the committee that it has…”
Editor's note · Context
Raskin highlights the disparity between profits and R&D spending on a drug.
Share
More from Jamie Raskin
Oct 2, 2026
President Trump is obviously desperate for the American people to ‘love’ him.
Sep 25, 2026
Yesterday’s consultation reinforces our sense that the Administration has turned America’s traditional refugee program into a whites-only airplane ride for South African Afrikaners into Trump’s America.
Oct 2, 2026
The American people are apparently paying for Donald Trump to create desperate preelection propaganda.
Sep 27, 2026
We need to zero in quickly on the forms of systemic corruption that have cost the public huge amounts of money, and where there are legislative cures available.
Other voices in this conversation
